Cleary, Wilson Sonsini Lead GSK's $1.9B Sierra Oncology Buy
U.K. drugmaker GlaxoSmithKline, guided by Cleary, will boost its ability to develop treatments for rare forms of cancer through the roughly $1.9 billion acquisition of Wilson Sonsini-advised Sierra Oncology, the companies...To view the full article, register now.
Already a subscriber? Click here to view full article